AstraZeneca Early Career Ovarian Cancer Research Grant supports fellows and early career faculty conducting innovative ovarian cancer research to generate preliminary data and build research independence.
Funder: Foundation for Women's Cancer
Due Dates: October 7, 2026 (LOI) | December 9, 2026 (Invited full proposal)
Funding Amounts: $50,000 for one year
Summary: Supports fellows and early career faculty conducting innovative ovarian cancer research while developing research independence.
Key Information: Research must take place at a U.S. institution; non-SGO members need a documented SGO co-investigator or sponsor.
The AstraZeneca Early Career Ovarian Cancer Research Grant is offered through the Foundation for Women's Cancer (FWC) as part of its 2026–2027 Research Grants program. It supports promising fellows and early career faculty during the transition to research independence, helping innovative ovarian cancer projects generate preliminary data and establish a foundation for future research and extramural funding.
Projects may involve basic, translational, clinical, or population-based research relevant to the prevention, diagnosis, treatment, or outcomes of gynecologic cancers. Additional consideration goes to proposals emphasizing DNA damage response, immuno-oncology, and antibody-drug conjugates. Applicants should demonstrate commitment to a career in gynecologic oncology research and explain how the proposed work advances their development as independent investigators.